| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 39.270 | 79.467 | 97.857 | 58.903 | 45.854 | 85.415 | 118.991 | 173.546 | 68.986 | 111.303 |
| Total Income - EUR | 39.099 | 79.585 | 97.926 | 58.969 | 48.034 | 85.415 | 119.057 | 175.543 | 72.558 | 111.742 |
| Total Expenses - EUR | 20.919 | 46.552 | 79.294 | 54.600 | 62.093 | 50.462 | 79.128 | 106.275 | 91.343 | 95.310 |
| Gross Profit/Loss - EUR | 18.180 | 33.033 | 18.633 | 4.369 | -14.059 | 34.952 | 39.929 | 69.268 | -18.784 | 16.431 |
| Net Profit/Loss - EUR | 17.013 | 30.645 | 16.123 | 3.779 | -14.796 | 32.547 | 36.359 | 65.126 | -19.313 | 13.998 |
| Employees | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 3 |
Check the financial reports for the company - Skindrome Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 34 | 2.505 | 1.248 | 32 | 0 | 0 | 0 | 12.712 | 10.762 | 7.496 |
| Current Assets | 26.752 | 45.023 | 94.276 | 96.718 | 16.323 | 57.728 | 59.993 | 94.158 | 32.212 | 19.460 |
| Inventories | 8.227 | 5.444 | 8.165 | 7.966 | 4.213 | 7.365 | 8.357 | 9.688 | 9.608 | 4.881 |
| Receivables | 2.432 | 8.289 | 23.348 | 23.365 | 12.012 | 41.460 | 49.239 | 81.934 | 22.408 | 14.171 |
| Cash | 16.093 | 31.291 | 62.763 | 65.387 | 98 | 8.903 | 2.397 | 2.536 | 196 | 408 |
| Shareholders Funds | 22.893 | 44.398 | 57.581 | 60.303 | 10.622 | 42.968 | 49.115 | 65.174 | 32.298 | 12.800 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.893 | 2.417 | 36.870 | 34.648 | 5.724 | 14.760 | 10.153 | 41.696 | 12.940 | 14.156 |
| Income in Advance | 0 | 801 | 1.159 | 1.884 | 0 | 0 | 980 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7411 - 7411" | |||||||||
| CAEN Financial Year |
7410
|
|||||||||
Comments - Skindrome Srl